EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CCL20/CCR6 signaling modulates disease severity during the establishment of Staphylococcus aureus osteomyelitis

Himanshu Meghwani iD, Javier Rangel-Moreno, Kyra M Sandercock, Motoo Saito, Katya A McDonald iD, Chloe M Kraft iD, Robert Constantine, Sophia Lenigk, Adryiana Rodriguez, Stephen L Kates, Jennifer H Jonason, Edward M Schwarz und 1 weitere

mBio · 2025

DOI: 10.1128/mbio.01413-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Himanshu Meghwani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Receptors, CCR6, Chemokine CCL20, Osteomyelitis, Staphylococcal Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIAID NIH HHS, American Association of Immunologists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemokines are essential mediators of immune responses, and the CCL20/CCR6 chemokine signaling axis is known to be involved in inflammation, infectious diseases, and cancer progression. However, the role of the CCL20/CCR6 axis in host defense against Staphylococcus aureus osteomyelitis remains unknown. We hypothesized that the CCL20/CCR6 axis is critical for the recruitment and activation of immune cells against S. aureus , and the lack of CCL20 or its monogamous receptor CCR6 leads to exacerbation of S. aureus osteomyelitis. In vitro studies confirmed that osteoblasts and macrophages (M0 and M2 subtypes) secrete CCL20 following S. aureus exposure. Implant-associated osteomyelitis in C57BL/6, CCL20 −/− , and CCR6 −/− mice revealed an early increase in planktonic bacterial growth on day 1 and increased bacterial loads in soft tissue and bone on day 14 post-infection in both CCL20 −/− and CCR6 −/− mice. Immunohistochemistry and flow cytometry revealed that CCL20 −/− and CCR6 −/− mice have impaired recruitment of T cells, especially CCR6 + T cells, to the site of infection. Interestingly, CCR6 −/− mice exhibited increases in osteoclast numbers, reactive bone formation, and reduced bone mineral density. In a clinical pilot study, we observed a fivefold increase in serum CCL20 levels ( P < 0.05) in S. aureus osteomyelitis patients ( n = 23) vs uninfected controls ( n = 10). Remarkably, serum CCL20 levels immediately following septic death were 100-fold higher vs uninfected patients ( P < 0.05). Collectively, these results highlight the critical role of CCL20/CCR6-mediated host immunity during the establishment of S. aureus osteomyelitis and the potential of CCL20 as a biomarker of osteomyelitis-induced sepsis. IMPORTANCE Staphylococcus aureus is the most common pathogen in orthopedic infections, and hard-to-treat strains (methicillin-resistant S. aureus ) cause >50% of these infections. Thus, there is an urgent need to develop immunotherapies to treat these life-threatening infections. The role of the CCL20/CCR6 chemokine signaling axis on S. aureus osteomyelitis is unknown. In our efforts to uncover its role, we reveal that osteoblasts and macrophages secrete CCL20 in response to infection, and mice lacking CCL20 or its monogamous receptor CCR6 are more susceptible to S. aureus osteomyelitis. Mechanistically, we observed that increased infection severity in the knockout mice is associated with decreased T cell recruitment and increased osteoclastogenesis at the bone infection site. Importantly, in a clinical pilot study, we observed that CCL20 can be a useful biomarker of osteomyelitis-induced septic death. Overall, our study highlights the crucial immunomodulatory role that the CCL20/CCR6 axis plays during osteomyelitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR6Chemokine CCL20OsteomyelitisStaphylococcal InfectionsStaphylococcus aureusSignal TransductionAnimalsMiceMice, Inbred C57BLMice, KnockoutMacrophagesHumansOsteoblastsDisease Models, AnimalFemaleMale

Stichwörter der Autor:innen

CCL20CCR6Staphylococcus aureusT cellshost immunityosteomyelitis

Substanzen

Receptors, CCR6Chemokine CCL20CCR6 protein, mouseCCL20 protein, mouseCCL20 protein, humanCCR6 protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York, USA.
  • Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
  • Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Department of Orthopedics, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Himanshu Meghwani, Katya A McDonald, Chloe M Kraft, Gowrishankar Muthukrishnan

Förderung

  • NIAMS NIH HHS
  • NIAID NIH HHS
  • American Association of Immunologists
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Meghwani, H., Rangel-Moreno, J., Sandercock, K. M., Saito, M., McDonald, K. A., Kraft, C. M., Constantine, R., Lenigk, S., Rodriguez, A., Kates, S. L., Jonason, J. H., Schwarz, E. M., & Muthukrishnan, G. (2025). CCL20/CCR6 signaling modulates disease severity during the establishment of Staphylococcus aureus osteomyelitis. mBio. https://doi.org/10.1128/mbio.01413-25

Vancouver

Meghwani H, Rangel-Moreno J, Sandercock KM, Saito M, McDonald KA, Kraft CM, et al. CCL20/CCR6 signaling modulates disease severity during the establishment of Staphylococcus aureus osteomyelitis. mBio. 2025. doi:10.1128/mbio.01413-25

BibTeX
@article{Meghwani2025,
  author = {Meghwani, Himanshu and Rangel-Moreno, Javier and Sandercock, Kyra M and Saito, Motoo and McDonald, Katya A and Kraft, Chloe M and Constantine, Robert and Lenigk, Sophia and Rodriguez, Adryiana and Kates, Stephen L and Jonason, Jennifer H and Schwarz, Edward M and Muthukrishnan, Gowrishankar},
  title = {CCL20/CCR6 signaling modulates disease severity during the establishment of Staphylococcus aureus osteomyelitis},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.01413-25}
}
Kostenlos starten →